We are international
Donate
• advocacy   TEXT SIZE   
IMF Advocacy    back

#AskDrDurie: My Maintenance was Stopped Because the Side Effects were Too Bad. How Common is That?
02.28.14

ask_dr_durie_banner

 

Have a question? Submit it to AskDrDurie@myeloma.org!
 

facebook
googleplus
twitter
youtube


We take questions every week - all are important, however Dr. Durie can only answer so many... so email us - as well as connect with us via one of the social media channels listed above - and we will get it to Dr. Durie!

Our archives are brimming with useful information directed at - and asked by - patients, caregivers, and other interested parties... so please watch the episodes below, and share them as much as possible so that others may benefit!


 

 

 


 related videos
 related articles
#AskDrDurie: What do...
#AskDrDurie: Why was...
#AskDrDurie: What's...
#AskDrDurie: Can Cyt...
#AskDrDurie: What ha...
#AskDrDurie: Can the...
#AskDrDurie: Is it p...
#AskDrDurie: What is...
#AskDrDurie: How doe...
#AskDrDurie: What is...
#AskDrDurie: Is auto...
#AskDrDurie: Has the...
#AskDrDurie: If Poma...
#AskDrDurie: Is ther...
#AskDrDurie: How can...
#AskDrDurie: Is it o...
#AskDrDurie: What ar...
#AskDrDurie: Should ...
#AskDrDurie: How can...
#AskDrDurie: Can a l...
#AskDrDurie: Does ag...
#AskDrDurie: Is MRI ...
#AskDrDurie: Are the...
#AskDrDurie: Are cl...
#AskDrDurie: How doe...
#AskDrDurie: Are PET...
#AskDrDurie: In ligh...
#AskDrDurie: Should ...
#AskDrDurie: If Myel...
#AskDrDurie: My Mai...
#AskDrDurie: My Doc...
#AskDrDurie: Is Stop...
#AskDrDurie: Does "...
#AskDrDurie: If Mye...
#AskDrDurie: I Need ...
#AskDrDurie: Is Part...
#AskDrDurie: Can Mye...
#AskDrDurie: What Ab...
#AskDrDurie: What Is...
#AskDrDurie: What Is...
#AskDrDurie: Should ...
#AskDrDurie: How Can...
#AskDrDurie: Are The...
#AskDrDurie: Should ...
#AskDr.Durie: Is Che...
#AskDrDurie: What Di...
#AskDrDurie: What's ...
#AskDrDurie: Is MGUS...
#AskDrDurie: ASCT Fo...
#AskDrDurie: Can Zom...
#AskDrDurie: Are Cat...
#AskDrDurie: How Do ...
#AskDrDurie: Is Kidn...
#AskDrDurie: Which o...
#AskDrDurie: How clo...
#AskDrDurie: Can Mye...
10 PASSI PER CURA MI...
10 Steps to Better C...
10 Steps to Happy Ho...
2011 IMF Holiday Gif...
New Study: The Searc...
Comprender El Tratam...
...
ABOUT BSRI™
ABOUT BSRI®
Advocacy Update - Ap...
Advocacy Update - Ma...
Advocacy Update - Oc...
Advocacy Update - Se...
Advocacy Update: The...
As the Bill Turns......
ASCO 2012: Dr. Pasho...
ASCO 2013: Dr. Jakub...
ASCO 2013: Dr. Lonia...
ASCO 2013: Dr. Pande...
ASCO 2013: Dr. Usman...
ASCO 2013: Dr. Weise...
ASH 2012: A PREVIEW
ASH 2013: Dr. Ken An...
ASH 2014: Dr. Shaji ...
ASH 2014: Dr. Shaji ...
Audio Recording of C...
August 2013 Advocate...
Best of ASH 2014 - W...
Breaking News: Pomal...
FDA Recognition of E...
Freelite and Hevylit...
Health Reform and Yo...
Highlights from the ...
IMF 6th Annual Comed...
IMF Board Member Edi...
IMF Nurse Leadership...
IMF Responds to Prop...
IMF TV
IMWG 2014 Conference...
Infoline
International Myelom...
It is Officially Mye...
jc test
Live from ASH 2012: ...
Live! The Boca Raton...
Living Well with Mye...
Living Well With Mye...
Myelom Merkur - Früh...
MYELOMA AWARENESS MO...
Myeloma Canada Annou...
Myeloma Minute Apri...
Myeloma Minute Apri...
Myeloma Minute Apri...
Myeloma Minute Febr...
Myeloma Minute Janu...
Myeloma Minute July...
Myeloma Minute June...
Myeloma Minute Marc...
Myeloma Minute May ...
Myeloma Minute Nove...
Myeloma Minute Octo...
Myeloma Minute Octo...
Myeloma Minute Sept...
Myeloma MinuteJune 1...
Myeloma MinuteMay 24...
Myeloma Today Spring...
New! Free Teleconfer...
News Briefing: The L...
One Myeloma Nation
Patienten Handbuch
Pomalidomide + carfi...
Should Myeloma Patie...
Special Myeloma Minu...
STEP 7: CONSOLIDATIO...
STEP 8: KEEPING TRAC...
Stillwater, Minn., M...
Teleconference: Myel...
The Emerging Role of...
The Hope Society
THE IMF AT ASH 2012
The IMF Gains Nation...
The IMF Spearheads N...
The Importance of Cl...
The IMWG Conference ...
The IMWG Conference ...
The International My...
The International My...
The International My...
View the IMF’s Multi...
Webcast from the 201...
Клиническое значение...

ASCO 2012: Dr. Pashos - Race- and health-related quality of life among patients newly diagnosed with multiple myeloma
ASCO 2013: Dr. Jakubowiak - Treatment outcome with the combination of carfilzomib, lenalidomide, and low-dose dexamethasone (CRd) for newly diagnosed multiple myeloma (NDMM) after extended follow-up.
ASCO 2013: Dr. Lonial - Phase (Ph) I/II study of elotuzumab (Elo) plus lenalidomide/dexamethasone (Len/dex) in relapsed/refractory multiple myeloma (RR MM): Updated Ph II results and Ph I/II long-term safety.
ASCO 2013: Dr. Pandey - Beneficial effect of complete response and type of therapy in multiple myeloma.
ASCO 2013: Dr. Usmani - Retrospective analysis of cardiovascular (CV) events following compassionate use of carfilzomib (CFZ) in patients (Pts) with relapsed and refractory multiple myeloma (RRMM).
ASCO 2013: Dr. Weisel - MM-003: A phase III, multicenter, randomized, open-label study of pomalidomide (POM) plus low-dose dexamethasone (LoDEX) versus high-dose dexamethasone (HiDEX) in relapsed/refractory multiple myeloma (RRMM).
jc test
#AskDrDurie: What does IMWG’s new diagnostic criteria mean for myeloma patients?
#AskDrDurie: Why wasn’t panobinostat approved?
#AskDrDurie: What's new at ASH 2014
#AskDrDurie: Can Cytoxan cause heart damage?
#AskDrDurie: What happens to stem cells once they are harvested?
#AskDrDurie: Can the Hevylite™ test be used to monitor IgA myeloma?
#AskDrDurie: Is it possible to have short remissions without high-risk features?
#AskDrDurie: What is remission?
#AskDrDurie: How does the IMF contribute to the myeloma community?
#AskDrDurie: What is Selinexor
#AskDrDurie: Is autologous stem cell transplant still recommended?
#AskDrDurie: Has there been any change in recommendations used to treat bone disease in myeloma?
#AskDrDurie: If Pomalyst does not produce a full response, what are my options?
#AskDrDurie: Is there a test available for measuring Minimal Residual Disease, what we call MRD?
#AskDrDurie: How can Revlimid’s diarrhea side effect be handled?
#AskDrDurie: Is it okay to take vitamin B12 on the same day as Velcade?
#AskDrDurie: What are the important aspects of different types of imaging, such as regular x-rays, MRI, CT, and PET?
#AskDrDurie: Should I have an ASCT if I've been through therapy and am in remission?
#AskDrDurie: How can myeloma suddenly go from standard to high risk?
#AskDrDurie: Can a low white blood cell count be enough to trigger a need for myeloma therapy?
#AskDrDurie: Does age make a difference in selecting myeloma treatment?
#AskDrDurie: Is MRI testing important to see if treatment is necessary for smoldering myeloma?
#AskDrDurie: Are there maintenance therapy recommendations for myeloma patients with t(4;14)?
#AskDrDurie: Are clinical trials part of the Black Swan Research Initiative(R), and if so, how can I participate?
#AskDrDurie: How does the new flow cytometry testing for MRD compare to molecular testing?
#AskDrDurie: Are PET/CT scans useful for a patient with MGUS?
#AskDrDurie: In light of Tom Brokaw's recent myeloma diagnosis, is better early screening required?"
#AskDrDurie: Should Patients With Similar Types of Myeloma Form Separate Support Groups?
#AskDrDurie: If Myeloma Is Diagnosed, Is It Okay to Start With A Holistic Type of Approach First?
#AskDrDurie: My Maintenance was Stopped Because the Side Effects were Too Bad. How Common is That?
#AskDrDurie: My Doctor Thinks the Myeloma Treatment is Damaging my Liver: Is That Correct?
#AskDrDurie: Is Stopping Pomalidomide After 1 Month Okay?
#AskDrDurie: Does "Big Data Analysis" Apply to Myeloma Patients?
#AskDrDurie: If Myeloma is CD 38 Positive, Shouldn't Anti-CD 38 Antibodies Work for All Patients?
#AskDrDurie: I Need to Have Surgery: Can I Do That?
#AskDrDurie: Is Partial Response Or Very Good Partial Response Good Enough?
#AskDrDurie: Can Myeloma Run In The Family?
#AskDrDurie: What About The Role Of Antibody Therapy In Myeloma?
#AskDrDurie: What Is "Off Label" Use?
#AskDrDurie: What Is Recommended for Smoldering Myeloma?
#AskDrDurie: Should I be in a Clinical Trial
#AskDrDurie: How Can Myeloma Patients Avoid Infection?
#AskDrDurie: Are There Special Precautions for Myeloma Patients in the Summer?
#AskDrDurie: Should I Be On Maintenance Therapy?
#AskDr.Durie: Is Chemobrain Real?
#AskDrDurie: What Diet Is Recommended For Myeloma Patients?
#AskDrDurie: What's New From ASCO/EHA/IMWG Summit?
#AskDrDurie: Is MGUS A Tumor, And What Is Being Done To Prevent It?
#AskDrDurie: ASCT For Younger Patients - Is Disease "Control" Sufficient?
#AskDrDurie: Can Zometa® be used alone to treat myeloma with bone disease?
#AskDrDurie: Are Cataracts a Side Effect of Treatment with Revlimid?
#AskDrDurie: How Do I Get Rid of Bone Pain?
#AskDrDurie: Is Kidney Transplant Possible for Myeloma Patients?
#AskDrDurie: Which of the new treatments are the most exciting?
#AskDrDurie: How close are we to a cure?
#AskDrDurie: Can Myeloma Run In The Family?
10 PASSI PER CURA MIGLIORE®
10 Steps to Better Care®
10 Steps to Stress Control – From Fear to Hope
10 Steps to Happy Holidays
2011 IMF Holiday Gift Boutique

New Study: The Search for Criteria to Diagnose Active Myeloma at an Early Stage

Comprender El Tratamiento con Dosis Altas con Rescate de Células Madre



Third in the popular series of debates that debuted in Amsterdam in 2012.

Conference aired at 1:00 pm CEST/7:00 am Eastern/4:00 am Pacific

ABOUT BSRI™
ABOUT BSRI®
Advocacy Update - April 2013
Advocacy Update - March 2013
Advocacy Update - October 2013
Advocacy Update - September 2012
Advocacy Update: The Healthcare Landscape in the Aftermath of the 2012 Elections
As the Bill Turns...Episode 3
ASCO 2012: Dr. Pashos - Race- and health-related quality of life among patients newly diagnosed with multiple myeloma
ASCO 2013: Dr. Jakubowiak - Treatment outcome with the combination of carfilzomib, lenalidomide, and low-dose dexamethasone (CRd) for newly diagnosed multiple myeloma (NDMM) after extended follow-up.
ASCO 2013: Dr. Lonial - Phase (Ph) I/II study of elotuzumab (Elo) plus lenalidomide/dexamethasone (Len/dex) in relapsed/refractory multiple myeloma (RR MM): Updated Ph II results and Ph I/II long-term safety.
ASCO 2013: Dr. Pandey - Beneficial effect of complete response and type of therapy in multiple myeloma.
ASCO 2013: Dr. Usmani - Retrospective analysis of cardiovascular (CV) events following compassionate use of carfilzomib (CFZ) in patients (Pts) with relapsed and refractory multiple myeloma (RRMM).
ASCO 2013: Dr. Weisel - MM-003: A phase III, multicenter, randomized, open-label study of pomalidomide (POM) plus low-dose dexamethasone (LoDEX) versus high-dose dexamethasone (HiDEX) in relapsed/refractory multiple myeloma (RRMM).
ASH 2012: A PREVIEW
ASH 2013: Dr. Ken Anderson's Overview
ASH 2014: Dr. Shaji Kumar's Overview
ASH 2014: Dr. Shaji Kumar's Overview
Audio Recording of Consensus on Care: Management of Side Effects of Novel Therapies Teleconference
August 2013 Advocate of the Month: Judy Lewis
Best of ASH 2014 - What Patients Need to Know
Breaking News: Pomalyst® (pomalidomide) Approved by the FDA for Relapsed Myeloma
FDA Recognition of Extended Survival with VELCADE® Indicates Important New Progress in Treating the Disease
Freelite and Hevylite will help the Black Swan Research Initiative find the best treatment to cure multiple myeloma
Health Reform and You: The ABC’s of the ACA for Private Health Insurance
Highlights from the 5th Annual IMWG Summit: Part 2
IMF 6th Annual Comedy Celebration
benefiting the Peter Boyle Research Fund
October 27, 2012
IMF Board Member Edith Mitchell, M.D., FACP, Named 2012 Recipient Of ASCO Humanitarian Award
IMF Nurse Leadership Board (NLB) White Paper on Subcutaneous Velcade® (bortezomib)
IMF Responds to Proposed Changes in CMS PET Scan Policy
IMF TV
IMWG 2014 Conference Series Debate: Making Sense of Treatment
Infoline
International Myeloma Foundation Expresses Disappointment at Oncologic Drugs Advisory Committee (ODAC) Recommendation Against New Myeloma Treatment Panobinostat
It is Officially Myeloma Awareness Month Across the Country!
jc test
Live from ASH 2012: Journalists’ Workshop with Leading Myeloma Experts
Live! The Boca Raton Patient & Family Seminar
Living Well with Myeloma Teleconference Series:
How to Prevent Infection in Myeloma Patients
Living Well With Myeloma:
Understanding the Immune System and Lab Values in Myeloma
Myelom Merkur - Frühjahr 2012 - #901
MYELOMA AWARENESS MONTH 2012 FACT-A-DAY
Myeloma Canada Announces Recipient of this Year’s Research Grant
Myeloma Minute
April 11, 2013
Myeloma Minute
April 18, 2013
Myeloma Minute
April 26, 2012
Myeloma Minute
February 7, 2013
Myeloma Minute
January 31, 2013
Myeloma Minute
July 26, 2012
Myeloma Minute
June 28, 2012
Myeloma Minute
March 7, 2013
Myeloma Minute
May 17, 2012
Myeloma Minute
November 8, 2012
Myeloma Minute
October 24, 2013
Myeloma Minute
October 25, 2012
Myeloma Minute
September 18, 2014
Myeloma Minute
June 13, 2013
Myeloma Minute
May 24, 2012
Myeloma Today Spring 2013
New! Free Teleconference: Myeloma Updates 2012
Post ASCO/EHA/IMWG Summit
News Briefing: The Latest on Blood Cancers – From Advances to Patient Advantages
One Myeloma Nation
Patienten Handbuch
Pomalidomide + carfilzomib trial recruiting patients.
Should Myeloma Patients Get a Flu Shot? If So, Which One?
Special Myeloma Minute on FDA Approved Data for VELCADE®, including long-term survival data
STEP 7: CONSOLIDATION AND MAINTENANCE - ARE THEY NEEDED? REFERENCES
STEP 8: KEEPING TRACK OF THE MYELOMA - MONITORING WITHOUT MYSTERY
Stillwater, Minn., Myeloma Support Group Marks "Centennial" Anniversary
Teleconference: Myeloma Updates 2012
Post ASCO/EHA/IMWG Summit
The Emerging Role of Kyprolis in the Treatment Paradigm
The Hope Society
THE IMF AT ASH 2012
The IMF Gains National Recognition for Myeloma Awareness Month in 2014
The IMF Spearheads New Coalition’s First Meeting on State Health Exchanges
The Importance of Clinical Trial Participation - A teleconference with Dr. Brian G. M. Durie
September 8,2011
The IMWG Conference Series "Making Sense of Treatment"
Dec. 8, 2014
The IMWG Conference Series "Making Sense of Treatment"
June 11, 2014
The International Myeloma Foundation announces partnership with Onyx Pharmaceuticals to support Black Swan Research Initiative®
The International Myeloma Foundation Reports Live from the 2013 ASH Meeting in New Orleans
The International Myeloma Foundation to Convene First Global Leaders Summit in Stockholm to Raise Disease Awareness and Increase Access to Life-Saving Treatments
View the IMF’s Multiple Myeloma Journalists’ Workshop and Webcast from ASH 2013 in New Orleans
Webcast from the 2014 Boca Raton Patient & Family Seminar
February 28 - March 1, 2014

Клиническое значение электрофореза белковых фракций


You might also be interested in:

#AskDrDurie: What does IMWG’s new diagnostic criteria mean for myeloma patients?

In this episode of #AskDrDurie, Dr. Brian Durie talks about the new diagnostic guidelines and tests that can be used to diagnose myeloma early, before CRAB features have emerged. These criteria have been published in a new publication available on myeloma.org.


#AskDrDurie: Why wasn’t panobinostat approved?

In this episode of #AskDrDurie, Dr. Brian Durie of the IMF answers a  patient's question about why the recent FDA ODAC hearing rejected the use of new drug panobinostat for myeloma. He also discusses other HDAC inhibitors that are currently in development.


#AskDrDurie: What's new at ASH 2014

In this week’s special #AskDrDurie episode, Dr. Brian Durie of the IMF takes a look at the December 2014 ASH (American Society of Hematology) meeting in San Francisco. He previews what abstracts will be presented and talks about news to expect out of the meeting.


#AskDrDurie: Can Cytoxan cause heart damage?

In this week's #AskDrDurie, the IMF's Dr. Brian G.M. Durie answers a patient's concern regarding myeloma treatment and heart damage--specifically when it comes to the drug Cytoxan.


#AskDrDurie: What happens to stem cells once they are harvested?

In this week's episode of #AskDrDurie, Dr. Brian G.M. Durie of the IMF answers a patient's question regarding stem cells. If they are harvested in a specific facility, can they be moved and stored elsewhere later?
 
Find out the answer in this video!


#AskDrDurie: Can the Hevylite™ test be used to monitor IgA myeloma?

In this week’s episode of #AskDrDurie, Dr. Brian Durie of the IMF answers a patient question regarding IgA myeloma and tests used to monitor it, specifically the Hevylite™ test. Watch this video to learn all about Hevylite.


#AskDrDurie: Is it possible to have short remissions without high-risk features?

Inspired by last week's #AskDrDurie episode in which Dr. Brian Durie of the IMF explained the definition of remission when it comes to  myeloma patients, this new episodes is a follow-up. Here, Dr. Durie explains why a myeloma patient might experience a short remission period, even if high-risk features have not been identified.


#AskDrDurie: What is remission?

In the latest episode of #AskDrDurie, Dr. Brian Durie of the IMF explains what remission means for myeloma patients.


#AskDrDurie: How does the IMF contribute to the myeloma community?

In the latest episode of #AskDrDurie, Dr. Brian Durie addresses a patient who has just learned about the IMF by explaining three key contributions the IMF makes to myeloma research and education.


#AskDrDurie: What is Selinexor

In this week's episode of #AskDrDurie, Dr. Brian Durie of the IMF takes a question from a patient who has relapsing myeloma and is wondering about the new drug Selinexor. Dr. Durie explains what the drug is and how it can be used in myeloma.


#AskDrDurie: Is autologous stem cell transplant still recommended?

In this episode of the IMF’s #AskDrDurie web series, Dr. Brian Durie talks about when and for what kind of myeloma patient an autologous stem cell transplant (ASCT) is recommended.


#AskDrDurie: Has there been any change in recommendations used to treat bone disease in myeloma?

In this week's episode of #AskDrDurie, the IMF's Chairman Dr. Brian Durie answers a patient's question regarding how bone disease in myeloma is treated. He discusses bisphosphonates such as Aredia and Zometa and what the current recommendations are.


#AskDrDurie: If Pomalyst does not produce a full response, what are my options?

In this episode of #AskDrDurie, Dr. Brian Durie explores options for myeloma treatment if a patient isn’t receiving a full response from Pomalyst.


#AskDrDurie: Is there a test available for measuring Minimal Residual Disease, what we call MRD?

In this week's #AskDrDurie, the IMF's Dr. Brian Durie answers a very important question regarding the tests available for measuring Minimal Residual Disease. As you may know, the IMF's Black Swan Research Initiative(R) has been evaluating a new flow test method for this, and it is becoming a new benchmark.


#AskDrDurie: How can Revlimid’s diarrhea side effect be handled?

In this episode of #AskDrDurie, the IMF's Dr. Brian Durie answers a patient's question about dealing with a specific side effect from Revlimid.


#AskDrDurie: Is it okay to take vitamin B12 on the same day as Velcade?

In this episode of #AskDrDurie, Dr. Brian Durie of the IMF answers a myeloma patient’s question about taking a supplement like vitamin B12 on the same day as Velcade.


#AskDrDurie: What are the important aspects of different types of imaging, such as regular x-rays, MRI, CT, and PET?
In this week's #AskDrDurie episode, Dr. Brian Durie of the IMF explains the difference between x-rays, MRI, CT, and PET image scans. Each one has its place in detecting myeloma, and he walks viewers through each.

#AskDrDurie: Should I have an ASCT if I've been through therapy and am in remission?

In this week's #AskDrDurie, IMF Chairman and Co-Founder, Dr. Brian Durie answers a patient's inquiry about the benefits and necessity of having an autologous stem cell transplant (ASCT) if treatment for myeloma has already been completed, with remission as the result.


#AskDrDurie: How can myeloma suddenly go from standard to high risk?
In this episode of #AskDrDurie, IMF Co-Founder and Chairman Dr. Brian G.M. Durie answers a patient submitted question regarding receiving an initial diagnosis of standard myeloma, having treatment, and then being told the myeloma was high risk. He explains when and why that can happen and discusses different kinds of testing involved.

#AskDrDurie: Can a low white blood cell count be enough to trigger a need for myeloma therapy?

In this episode of #AskDrDurie, IMF Chairman and Co-Founder Dr. Brian G.M. Durie talks about what a low white blood cell count means when it comes to myeloma.


#AskDrDurie: Does age make a difference in selecting myeloma treatment?

In this episode of #AskDrDurie, IMF Chairman and Co-Founder Dr. Brian G.M. Durie discusses the important factors one must consider when selecting individualized treatment for myeloma.


#AskDrDurie: Is MRI testing important to see if treatment is necessary for smoldering myeloma?

In this episode of #AskDrDurie, Dr. Brian Durie discusses the importance of MRI testing, specifically when it comes to patients with smoldering myeloma.


#AskDrDurie: Are there maintenance therapy recommendations for myeloma patients with t(4;14)?

In this episode of #AskDrDurie, IMF Chairman and Co-Founder Dr. Brian G.M. Durie addresses a question about what kind of maintenance therapy is recommended for those myeloma patients who have the t(4;14) chromosome abnormality.


#AskDrDurie: Are clinical trials part of the Black Swan Research Initiative(R), and if so, how can I participate?

In this episode of #AskDrDurie, Dr. Brian Durie, IMF Chairman and Co-Founder, talks about the Black Swan Research Initiative(R)'s various clinical trials and how eligible patients can get more information and potentially participate in them.


#AskDrDurie: How does the new flow cytometry testing for MRD compare to molecular testing?

In this episode of #AskDrDurie, Dr. Brian G.M. Durie, IMF Chairman and Co-Founder, discusses the sensitivity and accessibility of the flow cytometry method of MRD testing. 


#AskDrDurie: Are PET/CT scans useful for a patient with MGUS?

In this episode of #AskDrDurie, Dr. Brian G.M. Durie, IMF Chairman, explains what MGUS means and why PET/CT scans are the most effective way to exclude unsuspected lesions that may occur in patients.


#AskDrDurie: In light of Tom Brokaw's recent myeloma diagnosis, is better early screening required?"

In this episode of #AskDrDurie, Dr. Brian G.M. Durie, IMF Chairman, discusses the importance of early detection screenings in order to diagnose myeloma. Find out why there is a constant need for awareness and monitoring of any changes in test results.


#AskDrDurie: Should Patients With Similar Types of Myeloma Form Separate Support Groups?

#AskDrDurie: If Myeloma Is Diagnosed, Is It Okay to Start With A Holistic Type of Approach First?

#AskDrDurie: My Maintenance was Stopped Because the Side Effects were Too Bad. How Common is That?

#AskDrDurie: My Doctor Thinks the Myeloma Treatment is Damaging my Liver: Is That Correct?

#AskDrDurie: Is Stopping Pomalidomide After 1 Month Okay?

#AskDrDurie: Does "Big Data Analysis" Apply to Myeloma Patients?

#AskDrDurie: If Myeloma is CD 38 Positive, Shouldn't Anti-CD 38 Antibodies Work for All Patients?

#AskDrDurie: I Need to Have Surgery: Can I Do That?

#AskDrDurie: Is Partial Response Or Very Good Partial Response Good Enough?

#AskDrDurie: Can Myeloma Run In The Family?

#AskDrDurie: What About The Role Of Antibody Therapy In Myeloma?

#AskDrDurie: What Is "Off Label" Use?

#AskDrDurie: What Is Recommended for Smoldering Myeloma?

#AskDrDurie: Should I be in a Clinical Trial

#AskDrDurie: How Can Myeloma Patients Avoid Infection?

#AskDrDurie: Are There Special Precautions for Myeloma Patients in the Summer?

#AskDrDurie: Should I Be On Maintenance Therapy?

#AskDr.Durie: Is Chemobrain Real?

#AskDrDurie: What Diet Is Recommended For Myeloma Patients?

#AskDrDurie: What's New From ASCO/EHA/IMWG Summit?

#AskDrDurie: Is MGUS A Tumor, And What Is Being Done To Prevent It?

#AskDrDurie: ASCT For Younger Patients - Is Disease "Control" Sufficient?

#AskDrDurie: Can Zometa® be used alone to treat myeloma with bone disease?

#AskDrDurie: Are Cataracts a Side Effect of Treatment with Revlimid?

#AskDrDurie: How Do I Get Rid of Bone Pain?

#AskDrDurie: Is Kidney Transplant Possible for Myeloma Patients?

#AskDrDurie: Which of the new treatments are the most exciting?

#AskDrDurie: How close are we to a cure?